2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
22
Neoplasms
20
Leukemia, Myeloid, Acute
10
Ovarian Neoplasms
8
Neoplasm Metastasis
7
Lymphoma
7
Lung Neoplasms
7
Hematologic Neoplasms
6
Glioblastoma
6
Colorectal Neoplasms
6
Prostatic Neoplasms
5
Pancreatic Neoplasms
5
Multiple Myeloma
5
Leukemia
5
Fatigue
5
Stomach Neoplasms
4
Depression
4
Carcinoma, Non-Small-Cell Lung
4
Vulvar Neoplasms
3
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Triple Negative Breast Neoplasms
3
Sarcoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pain
3
Myelodysplastic Syndromes
3
Motor Activity
3
Melanoma
3
Fallopian Tube Neoplasms
3
Carcinoma, Hepatocellular
3
Interventions
Cognitive Training
2
Vitamin D
1
Tobacco Use Cessation Devices
1
Synbiotics
1
Sodium Chloride
1
Saline Solution
1
Prebiotics
1
Palliative Care
1
Neuroprotective Agents
1
Mesna
1
Magnetic Resonance Spectroscopy
1
High-Intensity Interval Training
1
Functional Status
1
Electroacupuncture
1
Drug Therapy
1
Doxorubicin
1
Cyclophosphamide
1
Ashwagandha
1
Acetylcysteine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Chemotherapy-Related Cognitive Impairment
×
Palliative Care
×
Clear all
NCT04586530
2026-01-21
TAMS
University of Pittsburgh
Phase NA
Active not recruiting
220 enrolled